Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
557 Leser
Artikel bewerten:
(2)

DGAP-HV: CORESTATE CAPITAL HOLDING S.A.: Bekanntmachung der Einberufung zur Hauptversammlung am 26.04.2019 in Luxemburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten.

DGAP-News: CORESTATE CAPITAL HOLDING S.A. / Bekanntmachung der Einberufung zur 
Hauptversammlung 
CORESTATE CAPITAL HOLDING S.A.: Bekanntmachung der Einberufung zur Hauptversammlung am 
26.04.2019 in Luxemburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG 
 
2019-03-25 / 15:02 
Bekanntmachung gemäß §121 AktG, übermittelt durch DGAP 
- ein Service der EQS Group AG. 
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 
 
CORESTATE CAPITAL HOLDING S.A. 4, rue Jean Monnet, 2180 Luxembourg, Luxembourg 
Registered with the Luxembourg Trade and Companies Register under registration number B 
199780 
 
Luxembourg, March 2019 
 
CONVENING NOTICE TO THE ANNUAL GENERAL MEETING OF THE SHAREHOLDERS 
 
The management board (the *Management Board*) of Corestate Capital Holding S.A. (the 
*Company*) hereby convenes all shareholders to the annual general meeting of the 
shareholders of the Company (the *Meeting*), which shall be held: 
 
on 26 April 2019 
at 10:00 a.m. CEST 
at Alvisse Parc Hotel, 120, Route d'Echternach, 
   L-1453 Luxembourg 
 
in accordance with articles 9 and 10.1 of the articles of association of the Company 
(the *Articles*). 
 
I.    *Quorum* 
 
      The amendments of the Articles proposed under items 9 and 10 of the below 
      agenda being extraordinary matters, article 10.2 of the Articles requires a 
      quorum of presence or representation of at least one half of the share capital 
      of the Company at the Meeting. In the event that this quorum is not met, 
      agenda items regarding an amendment of the Articles will be dropped. The 
      agenda items are adopted by a simple majority of the votes expressed by the 
      shareholders duly present or represented, except with regard to agenda items 9 
      and 10, for which a majority of 66.67% of the votes expressed by the 
      shareholders duly present or represented shall apply. 
II.   *Agenda* 
 
      01 *Presentation of the stand-alone annual 
         accounts of the Company for the financial 
         year 2018, of the approved consolidated 
         financial statements for the financial 
         year 2018 as well as the management 
         report for the financial year 2018* 
 
         The supervisory board of the Company (the 
         *Supervisory Board*) has not made any 
         comments to the stand-alone annual 
         accounts or the consolidated financial 
         statements for the financial year 2018 as 
         drawn up by the Management Board (the 
         *Financial Statements*). 
 
         The Management Board and the Supervisory 
         Board propose to the Meeting to approve 
         the Financial Statements and the report 
         of the independent auditor relating 
         thereto, in accordance with article 461-7 
         of the Luxembourg act on commercial 
         companies dated 10 August 1915, as 
         amended (the *Companies Act*). 
      02 *Acknowledgement of the profit of the 
         Company made with respect to the 
         financial year 2018 and allocation to the 
         legal reserve* 
 
         The Management Board proposes that the 
         Meeting acknowledges that the Company 
         made a profit with respect to the 
         financial year 2018 in an aggregate 
         amount of EUR 41,558,273.58 (the 
         *Profit*). 
 
         The Management Board proposes that the 
         Meeting resolves to (i) set off the 
         Profit against the losses carried forward 
         from the previous financial year, (ii) 
         subsequently allocate an amount of EUR 
         65,578.05 out of the balance to the legal 
         reserve of the Company, in accordance 
         with article 461-1 of the Companies Act, 
         and (iii) carry forward the balance of 
         profits in an aggregate amount of EUR 
         35,981,685.53 to the next financial year. 
      03 *Distribution out of the freely 
         distributable reserves of the Company* 
 
         The Management Board proposes that the 
         Meeting resolves to approve a 
         distribution out of the freely 
         distributable reserves of the Company in 
         an aggregate amount of EUR 53,386,042.50 
         (corresponding to EUR 2.50 per issued 
         share of the Company), to the 
         shareholders of the Company (the 
         *Distribution*). In view of a potential 
         share buy-back program, the number of 
         shares of the Company entitled to receive 
         a distribution could decrease in the 
         period up to the date on which the 
         proposed resolution on the Distribution 
         is passed, in which case the amount of 
         the Distribution per issued share of the 
         Company shall remain at EUR 2.50, but the 
         existing proposed Distribution resolution 
         shall automatically be adjusted 
         accordingly, to reflect the decrease in 
         the aggregate Distribution amount. The 
         approved Distribution shall be payable 
         within 3 business days as of the Meeting. 
      04 *Discharge (* _quitus_ *) to each of the 
         members of the Management Board for the 
         financial year 2018* 
 
         The Management Board and the Supervisory 
         Board propose to the Meeting to grant 
         discharge (_quitus_) to the present and 
         past members of the Management Board for 
         the performance of their duties as 
         members of the Management Board for, and 
         in connection with, the financial year 
         2018, except for Dr Michael Bütter, who 
         shall not be granted such discharge 
         (_quitus_). 
      05 *Discharge (* _quitus_ *) to each of the 
         members of the Supervisory Board for the 
         financial year 2018* 
 
         The Management Board and the Supervisory 
         Board propose to the Meeting to grant 
         discharge (_quitus_) to the members of 
         the Supervisory Board for the performance 
         of their duties as members of the 
         Supervisory Board for, and in connection 
         with, the financial year 2018. 
      06 *Appointment of a new member of the 
         supervisory board* 
 
         The Management Board proposes to the 
         Meeting to appoint Mr Jon Lurie, residing 
         in London, England, as a new member of 
         the Supervisory Board of the Company for 
         a term of office ending after the annual 
         general meeting of the Company which will 
         be held in 2021. 
 
         Further information about the proposed 
         candidate is available on the homepage at 
 
         www.corestate-capital.com 
 
         under 'Investor Relations' and 'Annual 
         General Meeting' and will be available 
         for inspection during the Meeting. A 
         curriculum vitae for the proposed 
         candidate, providing information about 
         his relevant knowledge, skills and 
         experience, together with a list of 
         relevant activities besides the 
         Supervisory Board position forming the 
         subject of this election, is attached as 
         Schedule 1 to this convening notice. 
      07 *Appointment of the independent auditor 
         (* _cabinet de révision agréé_ *) for the 
         financial year 2019* 
 
         The Supervisory Board proposes to the 
         Meeting to appoint Ernst & Young SA, 
         represented by partner Pavel Nesvedov, as 
         independent auditor (_cabinet de révision 
         agréé_) for the stand-alone annual 
         accounts and consolidated financial 
         statements of the Company for the 
         financial year 2019, and to grant power 
         and authority to the Management Board and 
         the Supervisory Board to enter into the 
         relevant agreement (in accordance with 
         market standards) with Ernst & Young SA. 
      08 *Authorisation to the Management Board to 
         buy back shares of the Company* 
 
         The Management Board proposes to the 
         Meeting to grant all powers to the 
         Management Board to buy back shares of 
         the Company for a period of 5 years 
         following the date of the present 
         Meeting. 
 
         The Management Board proposes that the 
         Meeting resolves that the aggregate 
         nominal amount of the shares of the 
         Company which may be acquired may not 
         exceed 10% of the aggregate nominal 
         amount of the issued share capital of the 
         Company from time to time, at the date of 
         exercise of the present authorisation. 
 
         In each individual case, the buyback is 
         to be conducted, at the choice of the 
         Management Board, (i) through the stock 
         exchange or (ii) by means of a purchase 
         offer addressed to all shareholders: 
 
         (i)  To the extent that the buyback is 
              conducted through the stock 
              exchange, the repurchase price per 
              share (excluding any ancillary 
              buyback costs and without any tax 
              gross-up obligation) paid by the 
              Company may not exceed or fall 
              short of, by more than 10%, of the 
              volume-weighted average of the 
              auction closing prices of shares of 
              the same class of the Company in 
              Xetra trading (or a functionally 
              comparable successor system to the 
              Xetra system) at the Frankfurt 
              Stock Exchange on the last three 
              exchange trading days before the 
              respective commitment to acquire. 
         (ii) To the extent that the buyback is 
              conducted through a purchase offer 
              addressed to all shareholders (the 
              *Offer*), the repurchase price per 

(MORE TO FOLLOW) Dow Jones Newswires

March 25, 2019 10:02 ET (14:02 GMT)

© 2019 Dow Jones News
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.